REYON Pharmaceutical Co., Ltd. (KRX:102460)
10,940
+150 (1.39%)
At close: Nov 4, 2025
REYON Pharmaceutical Market Cap
REYON Pharmaceutical has a market cap or net worth of 196.62 billion as of November 5, 2025. Its market cap has decreased by -21.75% in one year.
Market Cap
196.62B
Enterprise Value
396.83B
Revenue
150.05B
Ranking
n/a
PE Ratio
n/a
Stock Price
10,940.00
Market Cap Chart
Since June 10, 2010, REYON Pharmaceutical's market cap has increased from 164.55B to 196.62B, an increase of 19.48%. That is a compound annual growth rate of 1.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 196.62B | -16.51% |
| Dec 30, 2024 | 235.50B | -22.37% |
| Dec 28, 2023 | 303.36B | -21.07% |
| Dec 29, 2022 | 384.35B | -39.10% |
| Dec 30, 2021 | 631.11B | 61.64% |
| Dec 30, 2020 | 390.43B | 47.64% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 38.84T |
| ALTEOGEN | 29.36T |
| SK Biopharmaceuticals | 9.42T |
| Yuhan | 9.01T |
| HLB Co., Ltd. | 7.03T |
| Peptron | 6.33T |
| ABL Bio | 6.13T |